What Catherine spoke about.

Madam President, Mr Vice-President, dear Margaritis Schinas, the challenge of pharmaceutical legislation is to remake Europe into a strategic power for the development and production of medicines, a protective power. We are building this Europe of medicines fairly, with voluntary cooperation between Member States, in particular on the price of medicines, the extension of joint purchases for many t

Madam President, Commissioner, life expectancy has increased by five years between 2000 and 2015, it is estimated, although there are differences between regions of the world. This increase is mainly related to health progress. At the same time, however, the ageing of the population is accompanied by an increase in the prevalence of chronic diseases and cancers, which calls into question the guara

Mr President, Commissioner, ladies and gentlemen, the proposal to revise the legislation on medical devices and in vitro medical devices was published on 26 September 2012, following the health tragedy of PIP breast prostheses, which speaks - oh how much! – to the hospital practitioner I was then. Ten years later, the implementation of this legislation is still under discussion. Unfortunately, we

Madam President, Commissioner, ladies and gentlemen, this agreement illustrates our desire for a green transition that leaves no one behind: – because it will protect millions of workers, in particular in the renovation of buildings and batteries and their recycling; – because it will protect their jobs by not excluding them because of too high a blood lead, while monitoring them better (we avoid

Madam President, Commissioner, the COVID-19 crisis has shown us how any decision-making in the prevention, management and treatment of a disease depends on the availability and analysis of reliable, secure, comparable and even interoperable health data. This crisis has revealed the wide-ranging benefits of establishing a genuine European health data space. This new health data sharing space will:

Mr President, Commissioner, ladies and gentlemen, we have all become aware, throughout Europe, that the current model no longer guarantees us access to medicines, even essential medicines, in any situation. With the aim of the strategic autonomy that you support, Commissioner, a European law on critical medicines would serve our ambition to preserve, in equal rights, every European from a loss of

Mr President, Commissioner, ladies and gentlemen, asbestos is a long-term tragedy. For those who have been exposed, these are years of anxiety to fear the diagnosis of cancer. When the disease is finally diagnosed, tracing its origin is not easy, decades after exposure. The text we are about to vote on represents an important step in preventing occupational cancers by putting in place appropriate